Missense mutations in RYR2 were shown to be associated with catecholaminergic polymorphic ventricular tachycardia (CPVT), which is characterized by exercise-induced arrhythmias and sudden cardiac death. The gene discussed is RYR2; the disease is cardiac arrhythmia.